Cost-effectiveness study of nilotinib versus imatinib in the treatment of chronic myeloid leukemia in Vietnam - 14
2016, not based on real patient data when this data is being recommended for use in pharmacoeconomic studies and therefore sometimes does not accurately and fully reflect the actual treatment of patients. On the other hand, the authors study did not have a treatment group when estimating, as well ...